Medizinische Universität Graz - Research portal
Koll Florestan Johannes |
** = Publications listed in SCI/SSCI/Pubmed
2025
Full paper/article (Journal)
** Koll, FJ; Döring, C; Herwig, L; Hoeh, B; Wenzel, M; Cano, Garcia, C; Banek, S; Kluth, L; Köllermann, J; Weigert, A; Chun, FK; Wild, P; Reis, H
Impact of consensus molecular subtypes on survival with and without adjuvant chemotherapy in muscle-invasive urothelial bladder cancer.
J Clin Pathol. 2024; 78(1): 19-27.
Doi: 10.1136/jcp-2023-208973
Web of Science
PubMed
FullText
FullText_MUG
** Melero, I; de, Miguel, Luken, M; de, Velasco, G; Garralda, E; Martín-Liberal, J; Joerger, M; Alonso, G; Goebeler, ME; Schuler, M; König, D; Dummer, R; Reig, M; Rodriguez, Ruiz, ME; Calvo, E; Esteban-Villarrubia, J; Oberoi, A; Sabat, P; Soto-Castillo, JJ; Koster, KL; Saavedra, O; Sayehli, C; Gromke, T; Läubli, H; Ramelyte, E; Fortuny, M; Landa-Magdalena, A; Moreno, I; Torres-Jiménez, J; Hernando-Calvo, A; Hess, D; Racca, F; Richly, H; Schmitt, AM; Eggenschwiler, C; Sanduzzi-Zamparelli, M; Vilalta-Lacarra, A; Trojan, J; Koch, C; Galle, PR; Foerster, F; Trajanoski, Z; Hackl, H; Gogolla, F; Koll, FJ; Wild, P; Chun, FKH; Reis, H; Lloyd, P; Machacek, M; Gajewski, TF; Fridman, WH; Eggermont, AMM; Bargou, R; Schöniger, S; Rüschoff, J; Tereshchenko, A; Zink, C; da, Silva, A; Lichtenegger, FS; Akdemir, J; Rüdiger, M; L'Huillier, P; Dutta, A; Haake, M; Auckenthaler, A; Gjorgjioska, A; Rössler, B; Hermann, F; Liebig, M; Reichhardt, D; Schuberth-Wagner, C; Wischhusen, J; Fettes, P; Auer, M; Klar, K; Leo, E
Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours.
Nature. 2025; 637(8048):1218-1227
Doi: 10.1038/s41586-024-08305-z
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Wenzel, M; Hoeh, B; Koll, F; Humke, C; Fassl, A; Reis, H; Wild, P; Steuber, T; Graefen, M; Tilki, D; Traumann, M; Banek, S; Chun, FKH; Mandel, P
Impact of homologous recombination repair/BReast CAncer (BRCA) gene alterations on survival in a real-world setting of metastatic prostate cancer.
BJU Int. 2025; 135(1): 117-124.
Doi: 10.1111/bju.16462
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Wenzel, M; Hoeh, B; Siech, C; Koll, F; Humke, C; Groener, D; Steuber, T; Graefen, M; Maurer, T; Banek, S; Chun, FKH; Mandel, P
Lutetium-177 PSMA radioligand therapy in taxan-naive first- and second-line metastatic castration resistant prostate cancer after first-line ARPI therapy.
Eur J Nucl Med Mol Imaging. 2025;
Doi: 10.1007/s00259-025-07076-7
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Wenzel, M; Koll, F; Hoeh, B; Humke, C; Siech, C; Mader, N; Sabet, A; Groener, D; Steuber, T; Graefen, M; Maurer, T; Brandts, C; Banek, S; Chun, FKH; Mandel, P
Real-World Comparison of Cabazitaxel Versus 177Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer.
J Nucl Med. 2025; 66(1): 61-66.
Doi: 10.2967/jnumed.124.268807
Web of Science
PubMed
FullText
FullText_MUG
Correction
** Melero, I; de, Miguel, Luken, M; de, Velasco, G; Garralda, E; Martín-Liberal, J; Joerger, M; Alonso, G; Goebeler, ME; Schuler, M; König, D; Dummer, R; Reig, M; Rodriguez, Ruiz, ME; Calvo, E; Esteban-Villarrubia, J; Oberoi, A; Sabat, P; Soto-Castillo, JJ; Koster, KL; Saavedra, O; Sayehli, C; Gromke, T; Läubli, H; Ramelyte, E; Fortuny, M; Landa-Magdalena, A; Moreno, I; Torres-Jiménez, J; Hernando-Calvo, A; Hess, D; Racca, F; Richly, H; Schmitt, AM; Eggenschwiler, C; Sanduzzi-Zamparelli, M; Vilalta-Lacarra, A; Trojan, J; Koch, C; Galle, PR; Foerster, F; Trajanoski, Z; Hackl, H; Gogolla, F; Koll, FJ; Wild, P; Chun, FKH; Reis, H; Lloyd, P; Machacek, M; Gajewski, TF; Fridman, WH; Eggermont, AMM; Bargou, R; Schöniger, S; Rüschoff, J; Tereshchenko, A; Zink, C; da, Silva, A; Lichtenegger, FS; Akdemir, J; Rüdiger, M; L'Huillier, P; Dutta, A; Haake, M; Auckenthaler, A; Gjorgjioska, A; Rössler, B; Hermann, F; Liebig, M; Reichhardt, D; Schuberth-Wagner, C; Wischhusen, J; Fettes, P; Auer, M; Klar, K; Leo, E
Author Correction: Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours.
Nature. 2025; 639(8054):E18
Doi: 10.1038/s41586-025-08827-0
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2024
Full paper/article (Journal)
** Banek, S; Wenzel, M; Lauer, B; Le, QC; Hoeh, B; Koll, F; Cano, Garcia, C; Humke, C; Köllermann, J; Chun, FKH; Kosiba, M; Kluth, LA
Real-World Evidence of Tumor and Patient Characteristics and Survival with Avelumab Maintenance after Chemotherapy for Advanced and Metastatic Urothelial Carcinoma.
Urol Int. 2024; 108(4): 285-291.
Doi: 10.1159/000538237
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Falchetto, L; Bender, B; Erhard, I; Zeiner, KN; Stratmann, JA; Koll, FJ; Wagner, S; Reiser, M; Gasimli, K; Stehle, A; Voss, M; Ballo, O; Vehreschild, JJ; Maier, D
Concepts of lines of therapy in cancer treatment: findings from an expert interview-based study.
BMC Res Notes. 2024; 17(1): 137
Doi: 10.1186/s13104-024-06789-6
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Koll, FJ; Weers, L; Weigert, A; Banek, S; Köllermann, J; Kluth, L; Wenzel, M; Garcia, CC; Szarvas, T; Wessolly, M; Ingenwerth, M; Jeroch, J; Döring, C; Chun, FK; Wild, PJ; Reis, H
Histopathologic, Molecular, and Clinical Profiling of Lymphoepithelioma-like Carcinoma of the Bladder.
Mod Pathol. 2024; 37(11): 100588
Doi: 10.1016/j.modpat.2024.100588
Web of Science
PubMed
FullText
FullText_MUG
** Mandel, P; Hoeh, B; Humke, C; Doering, C; Wenzel, M; Cano, Garcia, C; Fuhr, N; Koll, F; Fassl, A; Tilki, D; Steuber, T; Faull, I; Jeroch, J; Ebner, S; Schmitt, C; Reis, H; Köllermann, J; Kokkaliaris, KD; Demes, MC; Chun, FKH; Wild, PJ
Feasibility of Next-generation Sequencing of Liquid Biopsy (Circulating Tumor DNA) Samples and Tumor Tissue from Patients with Metastatic Prostate Cancer in a Real-world Clinical Setting in Germany.
Eur Urol Focus. 2024; 10(2): 339-345.
Doi: 10.1016/j.euf.2024.02.007
Web of Science
PubMed
FullText
FullText_MUG
** Reis, H; Al-Ahmadie, H; Szarvas, T; Grünwald, V; Köllermann, J; Koll, F; Hadaschik, B; Chun, F; Wild, PJ; Paner, GP
[Rare tumors and tumor types of the urinary system in the 5th edition of the WHO classification 2022].
Pathologie (Heidelb). 2024; 45(6): 381-388.
Doi: 10.1007/s00292-024-01329-2
Web of Science
PubMed
FullText
FullText_MUG
** Siech, C; Wenzel, M; Grosshans, N; Cano, Garcia, C; Humke, C; Koll, FJ; Tian, Z; Karakiewicz, PI; Kluth, LA; Chun, FKH; Hoeh, B; Mandel, P
The Association Between Lymphovascular or Perineural Invasion in Radical Prostatectomy Specimen and Biochemical Recurrence.
Cancers (Basel). 2024; 16(21):
Doi: 10.3390/cancers16213648
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Stoll, AK; Koll, FJ; Eckstein, M; Reis, H; Flinner, N; Wild, PJ; Triesch, J
[Histomolecular classification of urothelial carcinoma of the urinary bladder : From histological phenotype to genotype and back].
Pathologie (Heidelb). 2024; 45(2): 106-114.
Doi: 10.1007/s00292-024-01305-w
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Wenzel, M; Hoeh, B; Humke, C; Koll, F; Cano, Garcia, C; Siech, C; Steuber, T; Graefen, M; Traumann, M; Kluth, L; Chun, FKH; Mandel, P
Influence of metastatic sites and burden on oncological outcomes in patients progressing to metastatic castration resistant prostate cancer.
World J Urol. 2024; 42(1): 615
Doi: 10.1007/s00345-024-05341-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Wenzel, M; Hoeh, B; Hurst, F; Koll, F; Cano, Garcia, C; Humke, C; Steuber, T; Tilki, D; Traumann, M; Banek, S; Chun, FKH; Mandel, P
Impact of PSA nadir, PSA response and time to PSA nadir on overall survival in real-world setting of metastatic hormone-sensitive prostate cancer patients.
Prostate. 2024; 84(13): 1189-1197.
Doi: 10.1002/pros.24754
Web of Science
PubMed
FullText
FullText_MUG
** Wenzel, M; Hoeh, B; Wagner, N; Koll, F; Siech, C; Humke, C; Steuber, T; Graefen, M; Tilki, D; Kluth, L; Traumann, M; Banek, S; Chun, FKH; Mandel, P
Treatment patterns and oncological outcomes of older adults with metastatic prostate cancer in real-world setting.
J Am Geriatr Soc. 2024; 72(9): 2700-2708.
Doi: 10.1111/jgs.19045
Web of Science
PubMed
FullText
FullText_MUG
** Wenzel, M; Koll, F; Hoeh, B; Humke, C; Reis, H; Wild, P; Steuber, T; Graefen, M; Tilki, D; Sabet, A; Gröner, D; Chun, FKH; Mandel, P
Cancer-Control Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer With BRCA Gene or Tumor Suppressor Mutations Undergoing 177-Lutetium Prostate-Specific Membrane Antigen Radioligand Therapy.
JCO Precis Oncol. 2024; 8: e2400645
Doi: 10.1200/PO-24-00645
Web of Science
PubMed
FullText
FullText_MUG
** Wenzel, M; Lutz, M; Hoeh, B; Koll, F; Cano, Garcia, C; Siech, C; Steuber, T; Graefen, M; Tilki, D; Kluth, LA; Banek, S; Chun, FKH; Mandel, P
Influence of Tumor Characteristics and Time to Metastatic Disease on Oncological Outcomes in Metachronous Metastatic Prostate Cancer Patients.
Clin Genitourin Cancer. 2024; 22(5): 102158
Doi: 10.1016/j.clgc.2024.102158
Web of Science
PubMed
FullText
FullText_MUG
** Wenzel, M; Siech, C; Hoeh, B; Koll, F; Humke, C; Tilki, D; Steuber, T; Graefen, M; Banek, S; Kluth, LA; Chun, FKH; Mandel, P
Contemporary Treatment Patterns and Oncological Outcomes of Metastatic Hormone-sensitive Prostate Cancer and First- to Sixth- line Metastatic Castration-resistant Prostate Cancer Patients.
Eur Urol Open Sci. 2024; 66: 46-54.
Doi: 10.1016/j.euros.2024.06.010
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Wenzel, M; Wagner, N; Hoeh, B; Siech, C; Koll, F; Cano, Garcia, C; Ahrens, M; Tilki, D; Steuber, T; Graefen, M; Banek, S; Chun, FKH; Mandel, P
Survival of patients with lymph node versus bone versus visceral metastases according to CHAARTED/LATITUDE criteria in the era of intensified combination therapies for metastatic hormone-sensitive prostate cancer.
Prostate. 2024; 84(14): 1320-1328.
Doi: 10.1002/pros.24767
Web of Science
PubMed
FullText
FullText_MUG
Review
** Banek, S; Hoeh, B; Cano, Garcia, C; Koll, F; Köllermann, J; Chun, FKH; Mandel, P; Kluth, LA; Wenzel, M
Metastatic Squamous Cell Carcinoma of the Urinary Bladder: Urgent Call for New Therapies.
Urol Int. 2024; 108(1): 1-8.
Doi: 10.1159/000534858
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2023
Full paper/article (Journal)
** Cano, Garcia, C; Wenzel, M; Koll, F; Zatik, A; Köllermann, J; Graefen, M; Tilki, D; Karakiewicz, PI; Kluth, LA; Chun, FKH; Mandel, P; Hoeh, B
Differences in long-term continence rates between prostate cancer patients with extraprostatic vs. organ-confined disease undergoing robotic-assisted radical prostatectomy: An observational studys.
Clinics (Sao Paulo). 2023; 78: 100284
Doi: 10.1016/j.clinsp.2023.100284
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Jahnen, M; Amiel, T; Wagner, T; Kirchhoff, F; Büchler, JW; Düwel, C; Koll, F; Westenfelder, K; Horn, T; Herkommer, K; Meissner, VH; Gschwend, JE; Lunger, L
Does experience change the role of systematic biopsy during MRI-fusion biopsy of the prostate?
World J Urol. 2023; 41(10): 2699-2705.
Doi: 10.1007/s00345-023-04564-z
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Koll, FJ; Banek, S; Kluth, L; Köllermann, J; Bankov, K; Chun, FK; Wild, PJ; Weigert, A; Reis, H
Tumor-associated macrophages and Tregs influence and represent immune cell infiltration of muscle-invasive bladder cancer and predict prognosis.
J Transl Med. 2023; 21(1): 124
Doi: 10.1186/s12967-023-03949-3
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Koll, FJ; Döring, C; Olah, C; Szarvas, T; Köllermann, J; Hoeh, B; Chun, FK; Reis, H; Wild, PJ
Optimizing identification of consensus molecular subtypes in muscle-invasive bladder cancer: a comparison of two sequencing methods and gene sets using FFPE specimens.
BMC Cancer. 2023; 23(1): 504
Doi: 10.1186/s12885-023-11016-9
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Koll, FJ; Metzger, E; Hamann, J; Ramos-Triguero, A; Bankov, K; Köllermann, J; Döring, C; Chun, FKH; Schüle, R; Wild, PJ; Reis, H
Overexpression of KMT9α Is Associated with Aggressive Basal-like Muscle-Invasive Bladder Cancer.
Cells. 2023; 12(4):
Doi: 10.3390/cells12040589
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Wenzel, M; Garcia, CC; Hoeh, B; Jorias, C; Humke, C; Koll, F; Tselis, N; Rödel, C; Graefen, M; Tilki, D; Chun, FKH; Mandel, P
Real-world evidence of outcomes of oligometastatic hormone-sensitive prostate cancer patients treated with metastasis-directed therapy.
Prostate. 2023; 83(14): 1365-1372.
Doi: 10.1002/pros.24599
Web of Science
PubMed
FullText
FullText_MUG
Review
** Maisch, P; Koll, F; Bolenz, C; Chun, FK; Gschwend, JE; Schmid, SC
Combination of radiation and immunotherapy in the treatment of genitourinary malignancies: A systematic review and meta-analysis.
Urol Oncol. 2023; 41(5): 219-232.
Doi: 10.1016/j.urolonc.2022.10.009
Web of Science
PubMed
FullText
FullText_MUG
2022
Full paper/article (Journal)
** Klawitter, M; El-Ayoubi, A; Buch, J; Rüttinger, J; Ehrenfeld, M; Lichtenegger, E; Krüger, MA; Mantwill, K; Koll, FJ; Kowarik, MC; Holm, PS; Naumann, U
The Oncolytic Adenovirus XVir-N-31, in Combination with the Blockade of the PD-1/PD-L1 Axis, Conveys Abscopal Effects in a Humanized Glioblastoma Mouse Model.
Int J Mol Sci. 2022; 23(17):
Doi: 10.3390/ijms23179965
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Koll, FJ; Schwarz, A; Köllermann, J; Banek, S; Kluth, L; Wittler, C; Bankov, K; Döring, C; Becker, N; Chun, FKH; Wild, PJ; Reis, H
CK5/6 and GATA3 Defined Phenotypes of Muscle-Invasive Bladder Cancer: Impact in Adjuvant Chemotherapy and Molecular Subtyping of Negative Cases.
Front Med (Lausanne). 2022; 9: 875142
Doi: 10.3389/fmed.2022.875142
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2021
Full paper/article (Journal)
** Koll, FJ; Meisenzahl, E; Haller, B; Maisch, P; Kirchhoff, F; Horn, T; Gschwend, JE; Schmid, SC
Evaluation of Pre-operative Biopsy, Surgical Procedures and Oncologic Outcomes in Upper Tract Urothelial Carcinoma (UTUC).
Front Surg. 2021; 8: 790738
Doi: 10.3389/fsurg.2021.790738
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Lunger, L; Retz, M; Bandur, M; Souchay, M; Vitzthum, E; Jäger, M; Weirich, G; Schuster, T; Autenrieth, M; Kübler, H; Maurer, T; Thalgott, M; Herkommer, K; Koll, F; Gschwend, JE; Nawroth, R; Heck, MM
KLK3 and TMPRSS2 for molecular lymph-node staging in prostate cancer patients undergoing radical prostatectomy.
Prostate Cancer Prostatic Dis. 2021; 24(2): 362-369.
Doi: 10.1038/s41391-020-00283-3
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Review
** Maisch, P; Retz, M; Gschwend, JE; Koll, F; Schmid, SC
Clinical Practice Guidelines for Bladder Cancer: A Systematic Review and Meta-Analysis Using the AGREE II Instrument.
Urol Int. 2021; 105(1-2): 31-40.
Doi: 10.1159/000509431
Web of Science
PubMed
FullText
FullText_MUG
2020
Full paper/article (Journal)
** Heck, MM; Koll, FJ; Retz, M; Autenrieth, M; Magg, K; Lunger, L; Gschwend, JE; Nawroth, R
Molecular lymph node staging for bladder cancer patients undergoing radical cystectomy with pelvic lymph node dissection.
Urol Oncol. 2020; 38(7): 639.e11-639.e19.
Doi: 10.1016/j.urolonc.2020.01.018
Web of Science
PubMed
FullText
FullText_MUG
** Schmid, SC; Koll, FJ; Rödel, C; Maisch, P; Sauter, A; Beckert, F; Seitz, A; Kübler, H; Flentje, M; Chun, F; Combs, SE; Schiller, K; Gschwend, JE; Retz, M
Radiation therapy before radical cystectomy combined with immunotherapy in locally advanced bladder cancer - study protocol of a prospective, single arm, multicenter phase II trial (RACE IT).
BMC Cancer. 2020; 20(1): 8
Doi: 10.1186/s12885-019-6503-6
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Review
** Schmid, SC; Koll, FJ; Beckert, F; Seitz, AK
[Immuno-oncological approaches in the perioperative therapy of muscle invasive bladder cancer].
Urologe A. 2020; 59(7): 790-796.
Doi: 10.1007/s00120-020-01234-5
Web of Science
PubMed
FullText
FullText_MUG
2019
Full paper/article (Journal)
** Lichtenegger, E; Koll, F; Haas, H; Mantwill, K; Janssen, KP; Laschinger, M; Gschwend, J; Steiger, K; Black, PC; Moskalev, I; Nawroth, R; Holm, PS
The Oncolytic Adenovirus XVir-N-31 as a Novel Therapy in Muscle-Invasive Bladder Cancer.
Hum Gene Ther. 2019; 30(1): 44-56.
Doi: 10.1089/hum.2018.026
Web of Science
PubMed
FullText
FullText_MUG